Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Vorinostat (Oral Route)
Drug Information provided by: MicromedexUS Brand Names
|
Description
Vorinostat is used to treat cutaneous T-cell lymphoma (CTCL). CTCL is a type of cancer that affects certain white blood cells and causes lesions to develop on the skin.
Vorinostat interferes with the growth of the cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by vorinostat, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Some unwanted effects may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.
Before you begin treatment with vorinostat, you and your doctor should talk about the benefits this medicine will do as well as the risks of using it.
This medicine is available only with your doctor's prescription.
Find Mayo Clinic on